Our depots have imlemented best practices of clinical trials logistics in compliance with GCP, GDP,GSP and GMP standarts Our depots have imlemented best practices of clinical trials logistics in compliance with GCP, GDP,GSP and GMP standarts Our depots have imlemented best practices of clinical trials logistics in compliance with GCP, GDP,GSP and GMP standarts

You are here

Clinical Trial Monitoring

SanaClis provides clinical monitoring services for phase II-IV clinical studies in the following countries in Central & Eastern Europe:

EU countries:

  • Slovakia
  • Czech Republic
  • Austria
  • Bulgaria
  • Croatia
  • Estonia
  • Germany
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovenia

non-EU countries:

  • Belarus
  • Bosnia and Herzegovina
  • Georgia
  • Macedonia
  • Montenegro
  • Russia
  • Serbia
  • Switzerland
  • Ukraine

Phase I studies can be done in Czech Republic, Ukraine and Russia.

Therapeutic Expertise

SanaClis can perform clinical monitoring in all / any therapeutic area incl. rare indications.
We have experience and pools of investigators in the following therapeutic areas:

  • Oncology
  • Cardiology
  • Psychiatry
  • Rheumatology
  • Respiratory
  • Metabolic
  • Immunology & Virology
  • Hepatology
  • Orthopedics
  • Hematology
  • Pain management
  • Neurology
  • Gynecology & Urology
  • Infections
  • Gastroenterology
  • Dermatology
  • Neonatology

Trials by therapeutic areas (n= 166)

Planned recruitment targets were exceeded or reached earlier in 94% of our studies

  • Feasibility process & Site selection
  • Pools of reliable investigators by therapeutic areas/indications
  • Country Databases of sites participating in clinical trials
  • Analysis of competitive studies and site workloadPre-study site evaluation visits
  • Set up of investigational sites
  • Investigator meeting (preparation, travel arrangements, conduct)
  • Study initiation
  • Site monitoring
  • Site management between the visits
  • Close-out visits and archiving

SanaClis CRAs

SanaClis CRAs have:

  • University education
  • Good command of English
  • All necessary trainings according to Sanaclis SOPs and individual training plans
  • Therapeutic area training
  • Supervised monitoring experience of at least 6 months before starting solo
  • 87% of CRAs have more than 2 years of clinical monitoring experience
  • strong social benefits and turnover close to zero
  • bonuses related to site quality and achievement of recruitment targets
  • SanaClis quality and safety net
  • obligation to provide any support to the sites (both proactive and on demand)
  • experience in active assistance with technical difficulties occurring at sites
  • availability & flexibility
  • As a result, our CRAs have mutually respectful and long-lasting working relationships with the investigators.
    Planned recruitment targets were exceeded or reached earlier in 94% of studies monitored by SanaClis CRAs

Tags: